Early detection of prostate cancer: AUA Guideline. - Wikidata - awgldk - TriplyDB

Early detection of prostate cancer: AUA Guideline.

Early detection of prostate cancer: AUA Guideline.

http://www.wikidata.org/entity/Q33608474

about

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer Clinical validity and utility of genetic risk scores in prostate cancer A comparison of genetic risk score with family history for estimating prostate cancer risk Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics Current state of prostate cancer treatment in Jamaica Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countries Temporal trends and racial disparities in global prostate cancer prevalence Urinary biomarkers for prostate cancer Androgens and prostate disease Multiparametric MRI in biopsy guidance for prostate cancer: fusion-guided Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening Prostate cancer characteristics in the World Trade Center cohort, 2002-2013 Prostate cancer screening in Brazil: should it be done or not?Robot-Assisted Radical Prostatectomy vs. Open Retropubic Radical Prostatectomy for Prostate Cancer: A Systematic Review and Meta-analysis Prostate cancer in Brazil and Latin America: epidemiology and screening Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.Population-based screening for cancer: hope and hype.Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.[Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data].Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohort Incorporating lag time to benefit into prevention decisions for older adults Metastatic prostate cancer in the modern era of PSA screening.Laser ablation as focal therapy for prostate cancer.Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort Defining the level of evidence for technology adoption in the localized prostate cancer pathway Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening.Need for and relevance of prostate cancer screening in Nigeria.

P2860

Q26739708-E237D29D-9091-47CF-9B08-ED86D3277598 Q26746219-BA4B94ED-6471-4D36-9E39-7603F27E3028 Q26752649-646E1872-C3DE-46CB-B8AC-82DFEB2025CE Q26778227-72E705BF-0AD8-4019-BF6B-952A30763B00 Q26830148-C2584998-EBBE-40F9-A103-624566444A8A Q26996461-C8F103CA-3CE0-4946-81CA-F89DC093BF17 Q27006994-D5AE8AF8-6806-48D4-968C-F0DA17D501D6 Q27009110-47411A10-60F7-4FC0-AA86-DC93762A05F8 Q27010093-80916D61-6EF1-46AD-B323-EF86E6B297BB Q27010554-C459068A-36D6-4920-81AB-CF73C1E27B87 Q27025805-CAA624B4-5571-4AC0-A425-B53555412360 Q28065062-28887A92-A6AB-4FC8-869B-089C2419EB24 Q28068688-6D850C0C-9662-4F4A-8E3A-318656198E9E Q28070886-3009B3DE-6803-490E-B21F-FC15C11F7D43 Q28079012-8B27DBB8-70FD-49FB-9C0A-C58833AD97DA Q28085419-37B13123-8F7C-4EE8-BCF4-317AE289000D Q28384774-68039CC2-17A5-43BD-B3A1-940629B0D93C Q28652628-2C070D7A-AC8E-4106-8BFC-FB31956180D9 Q30239973-CAC45DDD-B50B-4A40-BBE8-C4754D5CCFED Q30251601-86A5D446-5E5A-48C0-9E36-CD118E4E0F90 Q30406054-AD417FD9-BCF6-4A0D-B517-C364B07D8020 Q30422070-BE65D772-7B06-4F04-9B1F-BA12CAE66D43 Q30612397-7F1AD2E5-DB3E-4004-8384-0E60705B4A00 Q30698121-EE4520F9-7733-4B0A-9023-6C5DEDF2C37E Q30793372-05CFA00A-5F3F-4F11-8FAE-DF5BCD9208E1 Q30878080-75748B13-1849-45D9-8816-4DBFA20BF006 Q33568125-472A086A-C739-42D7-A242-AD553222670B Q33591357-746ED38E-CD52-467C-B9D7-6C611BE2596D Q33605381-97C8F7CA-D352-417A-8134-4E2E83BB50A1 Q33613656-61D2A8CD-74D4-453A-8A0F-A2BF522381DA Q33643656-657DD331-08AF-458D-9FE8-0FD8A41206FB Q33725622-E6E09E37-A434-4064-805C-28421513DF1E Q33772582-632932E1-C6E7-4284-9906-B899021C9A01 Q33807516-C65CC0A7-2498-4316-8DF4-CB31CDE4753D Q33883502-534A7BAB-80FD-4BA1-8255-713C7D78BB23 Q33890201-2F23110B-1CE3-4E51-9BD0-4FC060D2976F Q33980987-0C7B3E4D-00BA-479C-B655-826C99816902 Q34061419-C8EC5B0B-3CB5-49AA-9435-D8560EA2CA37 Q34084330-DA3B8715-818C-4A20-8BEE-9056159974E2 Q34135154-C43283B0-9090-401E-8C2C-CC3BD364CEA7

P2860

Early detection of prostate cancer: AUA Guideline.

http://www.wikidata.org/entity/Q33608474

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Early detection of prostate cancer: AUA Guideline.

@ast

Early detection of prostate cancer: AUA Guideline.

@en

type

label

Early detection of prostate cancer: AUA Guideline.

@ast

Early detection of prostate cancer: AUA Guideline.

@en

prefLabel

Early detection of prostate cancer: AUA Guideline.

@ast

Early detection of prostate cancer: AUA Guideline.

@en

P1433

Q33608474-CF27BB49-A024-494B-8306-C295B1F32489

P1476

Q33608474-9C26421E-939B-4468-9C9D-3C571E1DFCFB

P2093

Q33608474-13E77EDC-6FE1-4193-9E38-E049D2BE7422

Q33608474-3EDB5B2A-ADE8-42A0-BE07-58596702F0E8

Q33608474-53D16CFB-777C-4EC1-B062-DE95B85203F2

Q33608474-5C97E444-76E0-427F-A88F-02483A096667

Q33608474-B34F93A6-4478-4C2A-9E8B-C6D7828FA787

Q33608474-B4084FD4-9D49-494B-8FD8-A0D125FDD7D2

Q33608474-D1FFB534-BF3F-4754-8CA3-332381B04951

Q33608474-FCBEA7CB-307D-4EC7-A49A-EB90555BAD28

P2860

Q33608474-14B252F8-2653-40F1-AAFB-3613D9CD6D61

Q33608474-3A98CC40-F3D9-4522-BE16-9215013D2B1E

Q33608474-4CB52487-9EC6-4BFD-B36C-59607B627684

Q33608474-5ACA3F9C-B299-49B9-90F6-43869F1E1703

Q33608474-62F4220D-4D61-48FC-9E0A-35EA328D6FD4

Q33608474-64CABC31-1B27-46F3-8E0A-A487DD72402E

Q33608474-75D410EC-173E-491A-B150-C9C7000B75C6

Q33608474-773441FC-17FB-4E0E-B7A5-9E3AB90FEEB8

Q33608474-83C64862-1D3D-46AA-9539-E08148ABE711

Q33608474-964C01ED-4445-44C9-983B-DF0EBD1EFDC7

P304

Q33608474-4DB0D981-912E-4813-A31F-3EF2ADFB73F9

P31

Q33608474-F06C875A-5DE2-4ED9-AE2E-F91304EE045A

P356

Q33608474-EB5FAF17-4B3E-491A-800F-CD7E21654B01

P407

Q33608474-35F565CA-237E-4344-8E58-1065F4CF7940

P433

Q33608474-64EE6F6E-FA2B-461C-B0AF-E84BEAAF8987

P478

Q33608474-83178A35-4695-41E6-824C-AD3BED0DE7E1

P50

Q33608474-197A3BE3-5644-4F1B-B46C-09250FA0E855

Q33608474-272CA5DB-0BE9-4092-B5F2-B8DCF0C93A8A

Q33608474-5D32E36E-294F-4367-A5DC-E15A99723AE5

Q33608474-735C4261-2A49-4FD5-B89A-881F144C22AA

P577

Q33608474-93CC6207-43B5-4EA4-AF59-24F8EAD98034

P698

Q33608474-D6F78904-B64C-4E8B-9CC6-50414DB2306D

P932

Q33608474-4E811EFE-5DA4-4717-8FBD-2217EA77CAFB

P356

J.JURO.2013.04.119

P1433

The Journal of Urology

P1476

Early detection of prostate cancer: AUA Guideline.

@en

P2093

Anthony L Zietman

http://www.w3.org/2001/XMLSchema#string

Badrinath R Konety

http://www.w3.org/2001/XMLSchema#string

H Ballentine Carter

http://www.w3.org/2001/XMLSchema#string

Kirsten Lynn Greene

http://www.w3.org/2001/XMLSchema#string

Michael J Barry

http://www.w3.org/2001/XMLSchema#string

Peter C Albertsen

http://www.w3.org/2001/XMLSchema#string

Ruth Etzioni

http://www.w3.org/2001/XMLSchema#string

Stephen J Freedland

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Screening and prostate-cancer mortality in a randomized European study

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Prostate-cancer mortality at 11 years of follow-up.

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Prostate specific antigen testing among the elderly--when to stop?

Impact of comorbidity on survival among men with localized prostate cancer.

What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

P304

419-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2013.04.119

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad H. Murad

Philip W. Kantoff

David F. Penson

P577

2013-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23659877

http://www.w3.org/2001/XMLSchema#string

P932

4020420

http://www.w3.org/2001/XMLSchema#string